250 related articles for article (PubMed ID: 30421104)
1. Comparison of the effects of exercise and anti-TNF treatment on cardiovascular health in rheumatoid arthritis: results from two controlled trials.
Veldhuijzen van Zanten JJCS; Sandoo A; Metsios GS; Stavropoulos-Kalinoglou A; Ntoumanis N; Kitas GD
Rheumatol Int; 2019 Feb; 39(2):219-225. PubMed ID: 30421104
[TBL] [Abstract][Full Text] [Related]
2. Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis.
Cugno M; Ingegnoli F; Gualtierotti R; Fantini F
Curr Vasc Pharmacol; 2010 Mar; 8(2):285-92. PubMed ID: 19485909
[TBL] [Abstract][Full Text] [Related]
3. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
Jacobsson LT; Turesson C; Gülfe A; Kapetanovic MC; Petersson IF; Saxne T; Geborek P
J Rheumatol; 2005 Jul; 32(7):1213-8. PubMed ID: 15996054
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
5. Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial.
Heinze-Milne S; Bakowsky V; Giacomantonio N; Grandy SA
BMJ Open; 2017 Dec; 7(12):e018540. PubMed ID: 29275344
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?
Day AL; Singh JA
Drugs Aging; 2019 Jun; 36(6):493-510. PubMed ID: 30953327
[TBL] [Abstract][Full Text] [Related]
7. The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis.
Metsios GS; Moe RH; van der Esch M; van Zanten JJCSV; Fenton SAM; Koutedakis Y; Vitalis P; Kennedy N; Brodin N; Bostrom C; Swinnen TW; Tzika K; Niedermann K; Nikiphorou E; Fragoulis GE; Vlieland TPVM; Van den Ende CHM; Kitas GD;
Rheumatol Int; 2020 Mar; 40(3):347-357. PubMed ID: 31802210
[TBL] [Abstract][Full Text] [Related]
8. Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis.
Stavropoulos-Kalinoglou A; Metsios GS; Veldhuijzen van Zanten JJ; Nightingale P; Kitas GD; Koutedakis Y
Ann Rheum Dis; 2013 Nov; 72(11):1819-25. PubMed ID: 23155222
[TBL] [Abstract][Full Text] [Related]
9. The impact of cardiorespiratory fitness on classical cardiovascular disease risk factors in rheumatoid arthritis: a cross-sectional and longitudinal study.
Cooney JK; Ahmad YA; Moore JP; Sandoo A; Thom JM
Rheumatol Int; 2019 Oct; 39(10):1759-1766. PubMed ID: 31482199
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
Avouac J; Allanore Y
Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
[TBL] [Abstract][Full Text] [Related]
11. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis.
Tocci G; Goletti D; Marino V; Matucci A; Milano GM; Cantini F; Scarpa R
Expert Opin Drug Saf; 2016 Dec; 15(sup1):55-61. PubMed ID: 27924645
[TBL] [Abstract][Full Text] [Related]
13. Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Shen J; Shang Q; Tam LS
Transl Res; 2016 Jan; 167(1):138-51. PubMed ID: 26051628
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma.
Sarzi-Puttini P; Atzeni F; Shoenfeld Y; Ferraccioli G
Autoimmun Rev; 2005 Mar; 4(3):153-61. PubMed ID: 15823501
[TBL] [Abstract][Full Text] [Related]
15. Impact of short-term therapies with biologics on prothrombotic biomarkers in rheumatoid arthritis.
Jin T; Bokarewa M; Amu S; Tarkowski A
Clin Exp Rheumatol; 2009; 27(3):491-4. PubMed ID: 19604443
[TBL] [Abstract][Full Text] [Related]
16. Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.
van Breukelen-van der Stoep DF; Zijlmans J; van Zeben D; Klop B; van de Geijn GJ; van der Meulen N; Hazes M; Birnie E; Castro Cabezas M
Scand J Rheumatol; 2015; 44(6):443-8. PubMed ID: 26169960
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
Westlake SL; Colebatch AN; Baird J; Curzen N; Kiely P; Quinn M; Choy E; Ostor AJ; Edwards CJ
Rheumatology (Oxford); 2011 Mar; 50(3):518-31. PubMed ID: 21071477
[TBL] [Abstract][Full Text] [Related]
18. Exercise intervention on cardiorespiratory fitness in rheumatoid arthritis patients with high cardiovascular disease risk: a single-arm pilot study.
Sobejana M; van den Hoek J; Metsios GS; Kitas GD; van der Leeden M; Verberne S; Jorstad HT; Pijnappels M; Lems WF; Nurmohamed MT; van der Esch M
Clin Rheumatol; 2022 Dec; 41(12):3725-3734. PubMed ID: 36006555
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with parasympathetic activation following exercise in patients with rheumatoid arthritis: a cross-sectional study.
Osailan A; Metsios GS; Rouse PC; Ntoumanis N; Duda JL; Kitas GD; Veldhuijzen van Zanten JJ
BMC Cardiovasc Disord; 2016 May; 16():86. PubMed ID: 27165730
[TBL] [Abstract][Full Text] [Related]
20. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P
Ann Rheum Dis; 2005 Feb; 64(2):303-5. PubMed ID: 15231512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
